• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估[镓]镓-多胺多羧基大环配体-阿奇霉素作为细菌感染中细胞壁合成正电子发射断层显像潜在成像工具的性能。

Evaluation of [Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections.

作者信息

Koatale Palesa C, Welling Mick M, Mdanda Sipho, Mdlophane Amanda, Takyi-Williams John, Durandt Chrisna, van den Bout Iman, Cleeren Frederik, Sathekge Mike M, Ebenhan Thomas

机构信息

Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.

Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.

出版信息

Pharmaceuticals (Basel). 2024 Aug 31;17(9):1150. doi: 10.3390/ph17091150.

DOI:10.3390/ph17091150
PMID:39338315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11434960/
Abstract

The ability of bacteria to recycle exogenous amino acid-based peptides and amino sugars for peptidoglycan biosynthesis was extensively investigated using optical imaging. In particular, fluorescent AeK-NBD was effectively utilized to study the peptidoglycan recycling pathway in Gram-negative bacteria. Based on these promising results, we were inspired to develop the radioactive AeK conjugate [Ga]Ga-DOTA-AeK for the in vivo localization of bacterial infection using PET/CT. An easy-to-implement radiolabeling procedure for DOTA-AeK with [Ga]GaCI followed by solid-phase purification was successfully established to obtain [Ga]Ga-DOTA-AeK with a radiochemical purity of ≥95%. [Ga]Ga-DOTA-AeK showed good stability over time with less protein binding under physiological conditions. The bacterial incorporation of [Ga]Ga-DOTA-AeK and its fluorescent Aek-NBD analog were investigated in live and heat-killed () and (). Unfortunately, no conclusive in vitro intracellular uptake of [Ga]Ga-DOTA-AeK was observed for or live and heat-killed bacterial strains ( > 0.05). In contrast, AeK-NBD showed significantly higher intracellular incorporation in live bacteria compared to the heat-killed control ( < 0.05). Preliminary biodistribution studies of [Ga]Ga-DOTA-AeK in a dual-model of chronic infection and inflammation revealed limited localization at the infection site with non-specific accumulation in response to inflammatory markers. Finally, our study demonstrates proof that the intracellular incorporation of AeK is necessary for successful bacteria-specific imaging using PET/CT. Therefore, Ga-68 was not a suitable radioisotope for tracing the bacterial uptake of AeK tripeptide, as it required chelation with a bulky metal chelator such as DOTA, which may have limited its active membrane transportation. An alternative for optimization is to explore diverse chemical structures of AeK that would allow for radiolabeling with F or C.

摘要

利用光学成像广泛研究了细菌将外源氨基酸基肽和氨基糖循环利用以进行肽聚糖生物合成的能力。特别是,荧光AeK-NBD被有效地用于研究革兰氏阴性菌中的肽聚糖循环途径。基于这些有前景的结果,我们受到启发开发了放射性AeK共轭物[Ga]Ga-DOTA-AeK,用于使用PET/CT对细菌感染进行体内定位。成功建立了一种易于实施的用[Ga]GaCl对DOTA-AeK进行放射性标记的程序,随后进行固相纯化,以获得放射化学纯度≥95%的[Ga]Ga-DOTA-AeK。[Ga]Ga-DOTA-AeK在生理条件下随时间显示出良好的稳定性,且蛋白质结合较少。研究了[Ga]Ga-DOTA-AeK及其荧光Aek-NBD类似物在活的和热灭活的()和()中的细菌摄取情况。不幸的是,对于活的和热灭活的细菌菌株,未观察到[Ga]Ga-DOTA-AeK有确凿的体外细胞内摄取(>0.05)。相比之下,与热灭活对照相比,AeK-NBD在活细菌中显示出明显更高的细胞内掺入(<0.05)。[Ga]Ga-DOTA-AeK在慢性感染和炎症双模型中的初步生物分布研究表明,在感染部位的定位有限,且会因炎症标志物而出现非特异性积累。最后,我们的研究证明,AeK的细胞内掺入对于使用PET/CT成功进行细菌特异性成像至关重要。因此,Ga-68不是追踪AeK三肽细菌摄取的合适放射性同位素,因为它需要与诸如DOTA这样的大分子金属螯合剂螯合,这可能限制了其主动膜转运。优化的另一种方法是探索AeK的多种化学结构,以便能够用F或C进行放射性标记。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/b9fa302cb6cf/pharmaceuticals-17-01150-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/8a780c2827ba/pharmaceuticals-17-01150-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/307537519466/pharmaceuticals-17-01150-g0A2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/13bc8a32ea22/pharmaceuticals-17-01150-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/73773b6c0ac8/pharmaceuticals-17-01150-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/648e60846a05/pharmaceuticals-17-01150-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/801732fac940/pharmaceuticals-17-01150-g0A6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/acee80257313/pharmaceuticals-17-01150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/7de21ac4d78e/pharmaceuticals-17-01150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/a70dfbb8d691/pharmaceuticals-17-01150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/d9780445df99/pharmaceuticals-17-01150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/aa3a5d1db3dd/pharmaceuticals-17-01150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/ec46226c32af/pharmaceuticals-17-01150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/2913f033f5e5/pharmaceuticals-17-01150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/a12bcde31122/pharmaceuticals-17-01150-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/bc01ec90eca6/pharmaceuticals-17-01150-g009a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/b9fa302cb6cf/pharmaceuticals-17-01150-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/8a780c2827ba/pharmaceuticals-17-01150-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/307537519466/pharmaceuticals-17-01150-g0A2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/13bc8a32ea22/pharmaceuticals-17-01150-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/73773b6c0ac8/pharmaceuticals-17-01150-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/648e60846a05/pharmaceuticals-17-01150-g0A5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/801732fac940/pharmaceuticals-17-01150-g0A6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/acee80257313/pharmaceuticals-17-01150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/7de21ac4d78e/pharmaceuticals-17-01150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/a70dfbb8d691/pharmaceuticals-17-01150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/d9780445df99/pharmaceuticals-17-01150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/aa3a5d1db3dd/pharmaceuticals-17-01150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/ec46226c32af/pharmaceuticals-17-01150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/2913f033f5e5/pharmaceuticals-17-01150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/a12bcde31122/pharmaceuticals-17-01150-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/bc01ec90eca6/pharmaceuticals-17-01150-g009a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a814/11434960/b9fa302cb6cf/pharmaceuticals-17-01150-g010a.jpg

相似文献

1
Evaluation of [Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections.评估[镓]镓-多胺多羧基大环配体-阿奇霉素作为细菌感染中细胞壁合成正电子发射断层显像潜在成像工具的性能。
Pharmaceuticals (Basel). 2024 Aug 31;17(9):1150. doi: 10.3390/ph17091150.
2
Antimicrobial peptide LyeTx I mn∆K labeled with Ga is a potential PET radiopharmaceutical for molecular imaging of infections.用镓标记的抗菌肽LyeTx I mn∆K是一种用于感染分子成像的潜在正电子发射断层显像(PET)放射性药物。
Nucl Med Biol. 2024 Nov-Dec;138-139:108966. doi: 10.1016/j.nucmedbio.2024.108966. Epub 2024 Oct 16.
3
Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.新型双功能大环螯合剂的设计、合成及用于癌症诊断与治疗的临床前评价。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2618-2633. doi: 10.1007/s00259-022-05750-8. Epub 2022 Mar 26.
4
(68)Ga-labeled phage-display selected peptides as tracers for positron emission tomography imaging of Staphylococcus aureus biofilm-associated infections: Selection, radiolabelling and preliminary biological evaluation.(68)镓标记的噬菌体展示筛选肽作为金黄色葡萄球菌生物膜相关感染正电子发射断层扫描成像的示踪剂:筛选、放射性标记及初步生物学评价
Nucl Med Biol. 2016 Oct;43(10):593-605. doi: 10.1016/j.nucmedbio.2016.07.002. Epub 2016 Jul 11.
5
(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections.(68)镓-多胺多羧基大环配体-唾液酸结合免疫球蛋白样凝集素9正电子发射断层显像/计算机断层扫描成像观察种植体周围组织反应及葡萄球菌感染情况
EJNMMI Res. 2014 Aug 8;4:45. doi: 10.1186/s13550-014-0045-3. eCollection 2014.
6
Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.使用荧光和放射性镓标记的胃泌素释放肽受体拮抗剂对前列腺癌进行双模态成像
J Nucl Med. 2017 Jan;58(1):29-35. doi: 10.2967/jnumed.116.176099. Epub 2016 Aug 11.
7
Preclinical evaluation of potential infection-imaging probe [ Ga]Ga-DOTA-K-A9 in sterile and infectious inflammation.潜在感染成像探针[镓]Ga-DOTA-K-A9在无菌性和感染性炎症中的临床前评估
J Labelled Comp Radiopharm. 2018 May 23. doi: 10.1002/jlcr.3640.
8
Radiosynthesis and pre-clinical evaluation of [Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer.[镓]标记的抗菌肽片段GF-17作为潜在感染显像正电子发射断层显像(PET)放射性示踪剂的放射性合成及临床前评估
Appl Radiat Isot. 2019 Jul;149:9-21. doi: 10.1016/j.apradiso.2019.04.008. Epub 2019 Apr 10.
9
Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.评估用于靶向 VPAC 受体的 Ga-68 肽缀合物:稳定性和药代动力学。
Mol Imaging Biol. 2019 Feb;21(1):130-139. doi: 10.1007/s11307-018-1207-x.
10
Design, Synthesis, and Biological Evaluation of Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging.镓[68Ga]DOTAPhA1 的设计、合成与生物学评价:一种用于多种生长抑素受体成像的新型正电子发射断层扫描示踪剂。
Mol Pharm. 2018 Feb 5;15(2):619-628. doi: 10.1021/acs.molpharmaceut.7b00963. Epub 2018 Jan 19.

本文引用的文献

1
Insights into Peptidoglycan-Targeting Radiotracers for Imaging Bacterial Infections: Updates, Challenges, and Future Perspectives.洞悉靶向肽聚糖的放射性示踪剂在细菌感染成像中的应用:最新进展、挑战与未来展望。
ACS Infect Dis. 2024 Feb 9;10(2):270-286. doi: 10.1021/acsinfecdis.3c00443. Epub 2024 Jan 30.
2
Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging.临床前研究强调基于正电子发射断层扫描的放射性标记化合物感染成像的当代靶向机制。
Semin Nucl Med. 2023 Sep;53(5):630-643. doi: 10.1053/j.semnuclmed.2023.03.001. Epub 2023 Apr 2.
3
Imaging joint infections using D-methyl-C-methionine PET/MRI: initial experience in humans.
使用 D-甲基-C-蛋氨酸 PET/MRI 成像关节感染:初步人体经验。
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3761-3771. doi: 10.1007/s00259-022-05858-x. Epub 2022 Jun 23.
4
Synthesis and ex vivo biodistribution of two Ga-labeled tetrazine tracers: Comparison of pharmacokinetics.两种 Ga 标记的四嗪示踪剂的合成及体外生物分布:药代动力学比较。
Nucl Med Biol. 2022 Nov-Dec;114-115:151-161. doi: 10.1016/j.nucmedbio.2022.05.004. Epub 2022 May 24.
5
Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi, Met(O)]-Substance P for Future Clinical Application: First Experiences.迈向简便的放射性标记及镓-68/铋-213-DOTA-[硫代,甲硫氨酸(亚砜)]-P物质的制备以用于未来临床应用:初步经验
Pharmaceutics. 2021 Aug 25;13(9):1326. doi: 10.3390/pharmaceutics13091326.
6
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.FDG-PET/CT 在感染和炎症中的局限性和陷阱。
Semin Nucl Med. 2021 Nov;51(6):633-645. doi: 10.1053/j.semnuclmed.2021.06.008. Epub 2021 Jul 8.
7
PET/CT Imaging for Personalized Management of Infectious Diseases.用于传染病个性化管理的PET/CT成像
J Pers Med. 2021 Feb 16;11(2):133. doi: 10.3390/jpm11020133.
8
Imaging of Actively Proliferating Bacterial Infections by Targeting the Bacterial Metabolic Footprint with d-[5-C]-Glutamine.用 d-[5-C]-谷氨酰胺靶向细菌代谢足迹来对活跃增殖的细菌感染进行成像。
ACS Infect Dis. 2021 Feb 12;7(2):347-361. doi: 10.1021/acsinfecdis.0c00617. Epub 2021 Jan 21.
9
Small Molecule Sensors Targeting the Bacterial Cell Wall.靶向细菌细胞壁的小分子传感器
ACS Infect Dis. 2020 Jul 10;6(7):1587-1598. doi: 10.1021/acsinfecdis.9b00515. Epub 2020 Jun 9.
10
Regulation of peptidoglycan synthesis and remodelling.肽聚糖合成和重塑的调控。
Nat Rev Microbiol. 2020 Aug;18(8):446-460. doi: 10.1038/s41579-020-0366-3. Epub 2020 May 18.